Skip to main content
Free research Free research Free compound review with research home and workspace preview
Quick search ChEMBL 36
Compound Detail

CHEMBL1200959

METHDILAZINE
💊 Approved Drug
Enter ChEMBL ID:
Free Research Context This compound will appear in recent viewed items on the research home for this browser.
Research home View demo workspace
💊 Approved Drug
CN1CCC(CN2c3ccccc3Sc3ccccc32)C1

Basic Information

ChEMBL ID CHEMBL1200959
Name METHDILAZINE
Phase Approved
Structure Type MOL
InChI Key HTMIBDQKFHUPSX-UHFFFAOYSA-N
Therapeutic ✓ Yes

Known Names

Metdilazina Methdilazine Tacaryl
2
Targets
2
Activities
1
Assay Types
0
PK Parameters
4
Publications
3
Known Names
1
Indications
1
Mechanisms

Molecular Properties

296.4
MW (Da)
4.24
ALogP
3
HBA
0
HBD
6.5
PSA (Ų)
0.82
QED
0
Ro5 Violations
2
Rot. Bonds

Drug Information

Molecule Type Small molecule
First Approval 1982
Availability Discontinued
Chirality Racemic

Routes of Administration

Oral

Flags

Natural Product
USAN Stem -dil-; -lazine

Extended Properties

Molecular Formula C18H20N2S
MW 296.44
Aromatic Rings 2
Heavy Atoms 21
NP-Likeness -1.01

Mechanism of Action

Mechanism Action Type Target Direct Efficacy
Histamine H1 receptor antagonist ANTAGONIST Histamine H1 receptor

Indications

Hypersensitivity

ATC Classification

R06AD04
methdilazine
Level 1: RESPIRATORY SYSTEM
Level 2: ANTIHISTAMINES FOR SYSTEMIC USE

Activity Summary

IC50 2 meas. best 5.2

Target Activity Profile

Target Type Best pChEMBL Mean pChEMBL Best (nM) # Data
Unchecked
CHEMBL612545
IC50 5.2 5.2 6250.0 1
Chikungunya virus
CHEMBL4296563
IC50 4.95 4.95 11300.0 1

Activity Data Samples

Top measurements by pChEMBL value

Literature References

PubMed DOI Target Context # Activities
- 10.6019/CHEMBL4651402 SARS-CoV-2 4
28689975 10.1016/j.bmc.2017.06.049 Unchecked 2
- 10.6019/CHEMBL4651402 Vero C1008 2
28689975 10.1016/j.bmc.2017.06.049 Chikungunya virus 1

Data from ChEMBL 36 via Core Engine